Bolt Biotherapeutics Inc - ESG Rating & Company Profile powered by AI
Check the bottom of this webpage for potential risks for Bolt Biotherapeutics Inc based on industry, location and size. If you are employed by Bolt Biotherapeutics Inc and you would like to licence your Sustainability rating, please get in touch. The webpage is a zero-cost Environmental, Social and Governance assessment for Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.0, social score of 1.6 and governance score of 4.8.
2.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Akebia Therapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Bolt Biotherapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc offer flexible work?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Bolt Biotherapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Bolt Biotherapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Bolt Biotherapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Bolt Biotherapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Bolt Biotherapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Bolt Biotherapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Bolt Biotherapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; and BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.